182 related articles for article (PubMed ID: 26613228)
1. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
2. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
3. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
4. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
6. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
8. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
[TBL] [Abstract][Full Text] [Related]
9. Profound hypernatremia due to central diabetes insipidus.
Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
[TBL] [Abstract][Full Text] [Related]
10. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
Stapleton G; DiGeronimo RJ
J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
[TBL] [Abstract][Full Text] [Related]
11. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
12. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Insipidus Presenting with Oligohydramnios and Polyuria During Pregnancy.
Choi HS; Kim YH; Kim CS; Ma SK; Kim SW; Bae EH
J Nippon Med Sch; 2018; 85(3):191-193. PubMed ID: 30135348
[TBL] [Abstract][Full Text] [Related]
14. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
Fjellestad-Paulsen A; Crosnier H; Czernichow P
Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
[TBL] [Abstract][Full Text] [Related]
15. Delay in desmopressin therapy: Disaster in waiting.
Kroll C; Zandvakili A
J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
[TBL] [Abstract][Full Text] [Related]
16. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
Kamoi K
Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
[No Abstract] [Full Text] [Related]
17. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
18. Central diabetes insipidus following carbon monoxide poisoning.
Chang MY; Lin JL
Am J Nephrol; 2001; 21(2):145-9. PubMed ID: 11359023
[TBL] [Abstract][Full Text] [Related]
19. Polyuria due to central diabetes insipidus presenting as an early manifestation of acute myeloid leukemia.
Loukidis K; Papadakis E; Anagnostou N; Kiriklidou P; Gatsa E; Karagianni A; Patinakis P; Tsakiris D; Kioumi A; Korantzis I
Clin Adv Hematol Oncol; 2012 Jun; 10(6):399-400. PubMed ID: 22895244
[No Abstract] [Full Text] [Related]
20. [Central diabetes insipidus: diagnosis and management].
Ballan BK; Hernandez A; Rodriguez EG; Meyer P
Rev Med Suisse; 2012 Nov; 8(362):2158, 2160-4. PubMed ID: 23240316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
